Abstract
A pharmacokinetic analysis of a new antidepressant drug, mianserin (ORG GB-94), was undertaken in 4 male volunteers, each of whom received 15 mg mianserin on two occasions. Plasma levels peak at 2 h with a median level of 11.0 ng/ml, a median β-phase half-life of 10.0 h, and a median apparent volume of distribution of 3.3×103 l. EEG profile analysis shows mianserin to increase frequencies below 6 Hz, decrease those from 7.5 to 15 Hz, and increase frequencies above 18 Hz, a pattern similar to amitriptyline. Peak EEG effects range from 2 to 5 h with a pattern of measured changes that parallels plasma levels with varying latency. Decreases in vigilance measures and in critical flicker-fusion frequency show a similar time course.
Mianserin is a putative thymoleptic on EEG profile analysis with high cerebral penetrance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B., Åsberg, M., Tuck, D.: Relationship between the steady-state plasma concentration of nortriptyline and some of its pharmacological effects. In: Biological effects of drugs in relation to their plasma concentration, D. S. Davies and B. N. C. Prichard, eds., pp. 191–199. Baltimore: Univ. Park Press 1973
Åsberg, M., Cronholm, B., Sjöquist, F., Tuck, D.: Relationship between plasma level and therapeutic effect of nortriptyline. Br. Med. J. 3, 331–334 (1971)
Braithwaite, R. A., Goulding, R., Theano, G., Baily, J., Coppen, A.: Plasma concentration of nortriptyline and clinical response in depressive illness. Lancet 1972I, 1297–1300
Burrows, G. D., Davies, B., Scoggins, B. A.: Plasma concentration of nortriptyline and clinical response in depressive illness. Lancet 1972II, 619–623
Coppen, A., de Ridder, J. J.: A comparative trial of Org GB 94 and amitriptyline in the treatment of depressive illness, with measurement of drug plasma levels. Unpublished report, Organon Inc. No. 425, July 10, 1975
Fell, P. J., Quantock, D. C., van der Burg, W. J.: The human pharmacology of GB 94—a new psychotropic agent. Eur. J. Clin. Pharmacol. 5, 166–173 (1973)
Fink, M.: Electroencephalographic and behavioral effects of Tofranil. Can. Psychol. Assoc. J. 4, 166S-171S (1959)
Fink, M.: Quantitative electroencephalography in human psychopharmacology. II. Drug patterns. In: EEG and behavior, G. Glasser, ed., pp. 177–197. New York: Basic Books 1963
Fink, M.: EEG and human psychopharmacology. Ann. Rev. Pharmacol. 9, 241–258 (1969)
Fink, M.: EEG profiles and bioavailability measures of psychoactive drugs. In: Psychotropic drugs and the human EEG, T. Itil, ed., pp. 76–98. Munich: S. Karger 1974
Fink, M.: New strategies of psychotropic drug evaluation. In: Depressive illness and experiences with a new antidepressant drug GB 94, T. Vossenaar, ed., pp. 44–54. Amsterdam: Excerpta Medica 1975
Fink, M., Irwin, P.: Relation of EEG to blood levels of psychoactive drugs. In: Pharmacokinetics of psychoactive drugs: blood levels and clinical response, L. Gottschalk and S. Merlis, eds., pp. 243–250. New York: Spectrum Publications 1976
Fink, M., Irwin, P., Weinfeld, R. E., Schwartz, M., Conney, A. H.: Blood levels and EEG effects of diazepam and bromazepam. Clin. Pharmacol. Ther. 20, 184–191 (1976)
Fleischauer, J., van Riezen, H.: Untersuchungen zum klinischen und pharmakologischen Wirkungsbild der tetrazyklischen Substanz Mianserin. Arzneim. Forsch. 24, 1129–1131 (1974)
Gibaldi, M., Nagashima, R., Levy, G.: Relationship between drug concentration in plasma or serum and amount of drug in the body. J. Pharm. Sci. 58 (2), 193–197 (1969)
Hjorth, B.: EEG analysis based on time domain properties. Electroenceph. Clin. Neurophysiol. 29, 306–310 (1970)
Itil, T. M., Polvan, N., Hsu, W.: Clinical and EEG effects of GB 94, a ‘tetracyclic’ antidepressant. (EEG model in discovery of a new psychotropic drug.) Curr. Ther. Res. 14, 394–413 (1972)
Kety, S.: Physiological and physical factors governing the initial stages of drug distribution. In: Pharmacology and pharmacokinetics, T. Teorell, R. L. Dedrick, and P. G. Condliffe, eds., pp. 233–240. New York: Plenum Publishing 1974
Leonard, B. E.: Some effects of a new tetracyclic anti-depressant compound, Org GB 94 on the metabolism of monoamines in the rat brain. Psychopharmacologia 36, 221–236 (1974)
Perel, J. M., Shostak, M., Gann, E., Kantor, S. J., Glassman, A. H.: Pharmacodynamics of imipramine and clinical outcome in depressed patients. In: Pharmacokinetics of psychoactive drugs: blood levels and clinical response, L. Gottschalk and S. Merlis, eds., pp. 229–241. New York: Spectrum Publications 1976
van Riezen, H.: Different central effects of the 5-HT antagonists mianserine and cyproheptadine. Arch. de Pharmacody. et de Therap. 198, 256–269 (1972)
Shapiro, D. M., Glasser, M.: Measurement and comparison of EEG-drug effects. In: Psychotropic drugs and the human EEG, T. Itil, ed., pp. 327–349. Munich: S. Karger 1974
Simeon, J., Fink, M., Itil, T., Ponce, D.: d-Cycloserine therapy of psychosis by symptom provocation. Compr. Psychiatry 11, 80–88 (1970)
Vossenaar, T. (ed.): Depressive illness and experiences with a new antidepressant drug GB-94. Amsterdam: Excerpta Medica 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fink, M., Irwin, P., Gastpar, M. et al. EEG, blood level, and behavioral effects of the antidepressant mianserin (ORG GB-94). Psychopharmacology 54, 249–254 (1977). https://doi.org/10.1007/BF00426572
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426572